Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | N/A | 37.90 |
| PEG Ratio (TTM) | N/A | 5.33 |
| P/S Ratio (TTM) | N/A | 66.51 |
| P/B Ratio (TTM) | N/A | 72.67 |
| P/FCF Ratio (TTM) | N/A | 83.40 |
| Price to 5YR AVG Earnings Ratio | 11.96 | 13.84 |
| Price to 5YR AVG FCF Ratio | 18.70 | 46.20 |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | N/A | 648.99% |
| ROE (TTM) | N/A | 10.18% |
| Net Profit Margin (TTM) | N/A | -11.93% |
| ROIC 5YR AVG | 6.57% | 15.72% |
Growth (63%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -25.00% | 15.15% | 52.18% |
| Revenue | -25.00% | 12.20% | 38.51% |
| Net Income | -25.00% | 16.58% | 53.91% |
| Cash Flow | N/A | 80.96% | 83.60% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.28 | 5.01 |
| Quick Ratio (TTM) | -0.07 | 4.44 |
| D/E Ratio (TTM) | 0.30 | 0.85 |
| Interest Coverage (TTM) | N/A | 8.93 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 1.69 | 6.21 |
| LTL to 5YR AVG FCF | 5.76 | 7.60 |
| Shares Outstanding Growth 5YR AVG | 1.66% | 3.56% |